A sign marks a Biogen facility in Cambridge FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder Post navigation Previous: Biogen trims pipeline programs to cut costs, focus on Alzheimer’s drug launch